Roland P.T. Troquay

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 9.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol

Kausik K. Ray, Ulf Landmesser, Lawrence A. Leiter et al. · New England Journal of Medicine · 2017 · 977 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)

Steven E. Nissen, Qiuqing Wang, Stephen J. Nicholls et al. · JAMA · 2024 · 109 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study

Erik S.G. Stroes, John R. Guyton, Norman E. Lepor et al. · Journal of the American Heart Association · 2016 · 102 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial

Robbert J. de Winter, Yuki Katagiri, Taku Asano et al. · The Lancet · 2017 · 94 citations

Medicine, Cardiology, Biocompatibility +16